MineralsMagnesium

Combined apigenin and magnesium (A+M) synergistically enhances sleep duration in normal and insomnia mouse models

In normal mice, A+M treatment increased sleep duration by 44% (p<0.005). In caffeine-induced sleep disturbed mice, sleep duration increased by 32% (p<0.001), and in PCPA-induced insomnia mice, by 37% (p<0.05). These effects surpassed individual treatments of apigenin or magnesium alone.

Last updated: Jul 7, 20260 RCTs📖 Read as article →

Evidence Score

Evidence Score26/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

Study Evidence

Study 1. Synergistic sleep-promoting effects of magnesium and apigenin in normal and insomnia mouse models.

observational

Wong WY, Chan BD, Zhou H, Leung TC, Tai WC · Food &amp; function (2026)

Participants: N/A
Duration: N/A (not specified in abstract)
Intervention: Combined oral administration of apigenin and magnesium (A+M)
Outcome: Sleep duration, TNFα levels, microglial activation
Effect Size: 44% increase (normal mice, p<0.005), 32% increase (caffeine model, p<0.001), 37% increase (PCPA model, p<0.05)
Population: Normal mice, caffeine-induced sleep-disturbed mice, and PCPA-induced insomnia mice

Result:

Mechanism Graph

A+M treatment suppresses systemic and hypothalamic TNFα levels in PCPA-induced mice
A+M treatment inhibits microglial activation
Inhibition of microglial activation occurs potentially via suppressing NFκB signaling
Result: Enhanced sleep duration and restored sleep architecture

Limitations

  • Animal model study; results may not directly translate to humans
  • Dose and ratio of apigenin to magnesium not specified in abstract
  • Mechanistic pathway (NFκB) is inferred but not fully established

Frequently Asked Questions

What is the combined effect of apigenin and magnesium on sleep?

The combination significantly increases sleep duration in normal mice (44%) and in two insomnia models (32-37%), outperforming either compound alone.

How does apigenin and magnesium improve sleep?

The combination suppresses TNFα levels and inhibits microglial activation, potentially through blocking NFκB signaling, which reduces neuroinflammation.

Is this study done on humans?

No, this is an animal study using mouse models (normal, caffeine-induced, and PCPA-induced insomnia). Human trials are needed.

What are the limitations of this study?

Limitations include the use of animal models, lack of specified doses, and incomplete mechanistic confirmation.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Wong WY, Chan BD, Zhou H, Leung TC, Tai WC. "Synergistic sleep-promoting effects of magnesium and apigenin in normal and insomnia mouse models.." Food &amp; function, 2026. PMID: 41701207 DOI: 10.1039/d5fo04538j
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.